💚 Finding the right clinical trial can start with the right information.
HealthTree’s Clinical Trial Finder helps patients explore potential matches and come prepared for conversations with their care team.
Explore Clinical Trial Finder: healthtree.org/myeloma/find-…#ClinicalTrials#Myeloma#HealthTree
💚 He thought it was mono. It was ALL.
After chemotherapy, CAR T cell therapy, relapse, immunotherapy, and a stem cell transplant, William is now celebrating 6 years in remission.
His story offers hope to others navigating ALL.
📖 Read William’s full story on our Blood Cancer Awareness Month website: htree.org/blood-cancer-perso…#ALLAwareness#BloodCancerAwarenessMonth#AcuteLymphoblasticLeukemia
📍 Pasadena, CA | Oct. 3
Join us for HealthTree Connect to Cures! 💙
Meet fellow blood cancer patients & caregivers, hear from doctors, explore local resources, and take home practical tools for your care journey.
🤝 Connection
🩺 Expert panels
📚 Resources
🖤 Black community session
🎟️ Free & in person
⚠️ Not recorded — join us live!
👉 Register today! healthtree.org/myeloma/event…
Advance your #CLL expertise at this live virtual CME event on Oct. 12. Join Dr. Nicole Lamanna to discuss guideline-based treatment strategies, differences between fixed-duration and continuous therapy, and highlight shared decision-making approaches to optimize outcomes. activities.paradigmmc.com/14…@CllSociety@ParadigmMedCom
A complete health history can make a difference at every appointment.
Encourage your patients to organize their diagnosis, labs, scans, treatments, and medications in a Free HealthTree Personal Health Record.
Help your patients own their health story. healthtree.org/myeloma/perso…#OwnYourStory#PersonalizedSupport
Advance your #CLL expertise with this quiz-and-learn survey on guideline-based treatment selection, therapy sequencing, and shared decision-making.
Designated for a maximum of 0.25 AMA PRA Category 1 Credit™.
activities.paradigmmc.com/14…@ParadigmMedCom@CllSociety
Amazing panel discussion with Colorado experts at the HealthTree Denver Roundtable. Thank you Dr. Tara Gregory, Dr. Jorge Monge, Dr. Peter Forsberg, Dr. Jeff Matous and Kate Mimken, RN, BSN, FNP-C for a fabulous, educational day. #mmsm
Super science with in vivo CAR T - off-the-shelf product with no aoheresis, no lymphodepleting chemo, and possible as an outpatient therapy. HealthTree Denver Roundtable with Dr. Jeff Matous. #mmsm
New goals and new strategies using new tools in myeloma. “We are going to need these drugs.” Dr. Jeff Matous at the HealthTree Denver Roundtable. #mmsm
IVIG use should always happen with bispecific antibodies and we are learning how to administer them - space out the dosing or take treatment breaks - part of urgent questions to answer. Dr. Peter Forsberg at the HealthTree Denver Roundtable. #mmsm
Using bispecific antibodies in earlier lines makes sense. Better T cell function, combining bispecifics like Tec-Dara and other factors are showing stunning results. Dr. Peter Forsberg at the HealthTree Denver Roundtable. #mmsm
How to decide between CA R T and bispecific antibodies in your myeloma decision-making with Dr. Peter Forsberg at the HealthTree Denver Roundtable. #mmsm
Is transplant still recommended in newly diagnosed myeloma? In standard risk, it is still a choice for patients. @jmongemd HealthTree Denver Roundtable #mmsm
Learning from @jmongemd from the University of Colorado about smoldering myeloma and newly diagnosed myeloma - how to treat more personally - at the HealthTree Denver Roundtable. #mmsm
Richard Armstrong’s story highlights how a better understanding of health data can help patients take a more active role in their care and support more informed conversations with their care team.
Learn more about Richard’s story this Blood Cancer Awareness Month: healthtree.org/blood-cancer/…
Which multiple myeloma therapies are FDA- and EMA-approved right now, and how do you sequence them
for relapsed/refractory disease? Find out with our expert faculty at this @PeerView live symposium during
#IMS26: bit.ly/Glasgow2026-T#MultipleMyeloma
🩸 Leukemia changes lives, but it doesn’t define them.
Steve’s AML journey led him to a new purpose: supporting other blood cancer patients and helping power future breakthroughs through his Personal Health Record.
💚 Read his story: htree.org/blood-cancer-perso…
Own Your Story. Personalize Your Support. Power The Cure.
#LeukemiaAwarenessDay#AML#BloodCancer#HealthTree
A more complete health record can support more informed care.
HealthTree helps patients bring their health data together in one place, making it easier to access and share their health story when it matters.
Learn more: healthtree.org/myeloma/perso…#HealthTree#BloodCancer
🤝 Managing care across multiple doctors and specialists can be challenging.
Join HealthTree Foundation + Dr. Farrukh Awan to learn practical strategies for better communication, smoother care transitions, and stronger coordination across your healthcare team. 💙
Join us and take an active role in your care! healthtree.org/all-cancers/e…
🩸 A new treatment option for essential thrombocythemia (ET) has been approved.
The FDA approved Besremi (ropeginterferon alfa-2b-njft) for adults with ET, the first new agent approved in the U.S. for ET since 1997. 🔎
healthtree.org/my-app/news/0…
👉 Read the full article to learn more.
Three minutes. That's all it takes for someone's life to change forever.
This is just the beginning. ❤️
Watch our #BloodCancerAwarenessMonth trailer, share it, and help us make some noise!
Stay tuned all September. More stories, resources & ways to take action are coming.
Own Your Story. Personalize Your Support. Power The Cure.
#HealthTree#OwnYourStory
🩺 Less paperwork. More focus on your health. HealthTree is part of the CMS “Kill the Clipboard” initiative to make healthcare more connected and easier to navigate.
Join Todd Foster to learn how CLEAR and HealthEx can help simplify identity verification and medical record connections.
💙 Register now: healthtree.org/all-cancers/e…
Join us Sept. 12 for the Denver Myeloma Roundtable to hear from leading experts about the latest in myeloma treatment and research. Patient-friendly presentations, breakout sessions & live Q&A.
📍 Sheraton Denver Downtown Hotel
🔗healthtree.org/myeloma/commu…#Myeloma#Denver
Last call to join the 2026 HealthTree Challenge: Hike & Wellness Event! 🥾🌲
Whether you're a seasoned hiker or just getting started, you’ll have a community beside you every step of the way. 💬 Comment “HIKE” and we’ll send you the details!
piped.video/watch?v=9QaJbnwu…#HealthTreeChallenge#Vail2026
💙🩸 HealthTree Connect to Cures is coming to Des Moines, Iowa! Join fellow blood cancer patients & caregivers for a FREE day of connection, learning, local resources, and support. 🤝
📅 Saturday, September 19
📍 Sheraton West Des Moines Hotel
🥗 Lunch, parking & beverages provided!
🎟️ Register: healthtree.org/myeloma/event…
In-person event; not recorded. Join us live!
Iberdomide was FDA approved today, August 13, 2026, under the brand name ZENBEXUS™. It received accelerated approval in combination with daratumumab/hyaluronidase + dexamethasone (ZDd) #mmsm#myelomapiped.video/5SCEEea5VSU
Our HealthTree Coaches came together to learn, reflect, and connect. 💚 Because coaching is more than sharing experiences, it’s about showing up, listening, and helping others feel less alone.
Together, we care. Together, we cure. 🌱
New AACR research is exploring CAR T-cell therapy for high-risk smoldering myeloma. The CAR-PRISM study offers an early look at how treatment strategies could evolve. healthtree.org/myeloma/commu…#MMsm#MultipleMyeloma
Which multiple myeloma therapies are FDA- and EMA-approved right now—and how do you sequence them
for relapsed/refractory disease? Find out with our expert faculty at this @PeerView live symposium during
#IMS26: bit.ly/Glasgow2026-T#MultipleMyeloma
Help your blood cancer patients discover a free educational event where they can hear from blood cancer experts, connect with local support organizations, and meet others in the community.T
Thank you, Dr. @salmanf, for helping empower the blood cancer community.
Learn more: healthtree.org/blood-cancer/…#BloodCancer#Pittsburgh